BP000295-CHM-267: Recombinant Rat C-X-C Motif Chemokine 5 (CXCL5) Protein
Source: E. coli-derived.
Determined by its ability to chemoattract human peripheral blood neutrophils using a concentration range of 10.0-100.0 ug/ml.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000395-DEN-011: Recombinant Dengue Virus Subtype 1 Envelope 15 kDa, C-Terminal (Domain III)
Source: E. coli-derived.
Purity > 95%, by 12% PAGE.BP000300-CHM-274: Recombinant Human C-X-C Motif Chemokine Ligand 7 (CXCL7) Protein
Source: E. coli-derived.
The specific activity as determined by the ability of NAP2 to chemoattract human neurotrophils using a
concentration of 1-10 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000300-CHM-269: Recombinant Rat C-X-C Motif Chemokine Ligand 7 (CXCL7) Protein
Source: E. coli-derived.
Measured by its ability to chemoattract BaF3 mouse pro-B cells transfected with human CXCR2. The ED50 for this effect is less than 10 ug/ml, corresponding to a specific activity of 100,000 units/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000300-CHM-277: Recombinant Human C-X-C Motif Chemokine Ligand 7 95 a.a. Protein
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.BP000295-CHM-365: Recombinant Mouse C-X-C Motif Chemokine 5 (CXCL5) Protein
Source: E. coli-derived.
Determined by its ability to chemoattract human peripheral blood neutrophils using a concentration range of 10-100 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000295-CHM-265: Recombinant Human C-X-C Motif Chemokine 5 (CXCL5) Protein
Source: E. coli-derived.
The biological activity was determined by its ability to chemoattract human peripheral blood neutrophils using a concentration range of 10.0-100.0 ug/ml.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000295-CHM-331: Recombinant Human C-X-C Motif Chemokine 5 (CXCL5) Protein
Source: E. coli-derived.
The biological activity was determined by measuring the dose dependent mobilization of intracellular calcium (calcium flux) with human neutrophils. Significant calcium mobilization is observed with 100 ug/ml (corresponding to a Specific Activity of 10,000 IU/mg) of recombinant human ENA-78.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000302-CHM-243: Recombinant Human C-X-C Motif Chemokine Ligand 4 (CXCL4) Variant 1 Protein
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP000302-CHM-234: Human C-X-C Motif Chemokine Ligand 4 (CXCL4) Protein
Source: Human Platelets-derived.
Purity: > 95% by RP-HPLC and SDS-PAGE.